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Research into dietary factors associated with hypertension has focused on the sodium com-
ponent of salt. However, chloride has distinct physiological effects that may surpass the
effect of sodium on blood pressure. This study aims to separate the specific effects of chlo-
ride and sodium intake on blood pressure.
Methods
We studied 5673 participants from the Prevention of Renal and Vascular End-Stage Dis-
ease(PREVEND) study. Urinary chloride(uCl) and sodium(uNa) were measured in two 24-
hour collections. We used generalized-linear-regression to evaluate the relation of uCl and
uNa with baseline blood pressure and Cox-proportional-hazards-analysis to assess the
association with hypertension. Multicollinearity was assessed with Ridge regression.
Results
Baseline 24-hour uCl was 135±39mmol and uNa was 144±54mmol. The correlation
between uCl and uNa was high (Pearson’s r = 0.96). UCl and uNa had similar non-significant
positive and linear associations with blood pressure. In 3515 normotensive patients, 1021
patients developed hypertension during a median follow-up of 7.4 years. UCl and uNa had a
comparable but non-significant J-shaped effect on the risk of hypertension. Adding both uCl
and uNa to the same model produced instability, demonstrated by Ridge coefficients that
converged or changed sign. The single index of uNa minus uCl showed a non-significant
higher risk of hypertension of 2% per 10mmol/24-hour difference (HR1.02, 95%CI 0.98–
1.06).
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Conclusion
UCl and uNa had similar positive but non-significant associations with blood pressure and
risk of hypertension and their effects could not be disentangled. Hence, the alleged adverse
effects of high salt intake could be due to sodium, chloride or both. This encourages further
study into the effect of chloride in order to complement dietary recommendations currently
focused on sodium alone.
Introduction
Hypertension is an important modifiable risk factor for renal and cardiovascular disease[1].
Research into nutritional factors associated with development of hypertension has mainly
focused on the cations sodium and potassium[2,3]. Although the importance of chloride in
hypertension was suggested more than a century ago, its direct role on blood pressure is still
equivocal[4]. As a result, major guidelines contain dietary recommendations focused on
sodium alone [5–7].
Despite the focus on sodium, the accompanying anion–chloride–may also play an impor-
tant role. Chloride is associated with plasma renin suppression, metabolic acidosis and vaso-
constriction of the afferent arteriole of the glomerulus and a subsequent reduction in the
glomerular filtration rate[8,9]. Preliminary data suggested that the negative effects of high
sodium salt consumption may depend on concomitant chloride intake. First, in animals stud-
ies the chloride component of dietary salt produced hypertension and suppressed renin
release, independent of the associated cation[10–14]. Second, exploratory studies in humans
showed that blood pressure was lower with non-chloride sodium salt loading (e.g. sodium
bicarbonate, -citrate or -phosphate) compared with sodium chloride loading[15–18]. Third,
the beneficial effect of potassium supplementation might be mitigated by concomitant chloride
intake[19–21]. Notably, most studies investigating potential benefits of sodium restriction, did
not include chloride in their analysis[22,23].
Restricting sodium intake without lowering chloride intake disregard the pathophysiologi-
cal effects of chloride and may have unintended effects on blood pressure. Since sodium reduc-
tion will mostly be effectuated by lowering salt (i.e. sodium chloride) intake, the beneficial
effects of sodium reduction in previous studies could also result from concurrent chloride
reduction. Although sodium restriction is assumed to result in a similar reduction in chloride,
analysis of various food demonstrated that sodium and chloride contents can be different
[24,25]. In addition, current dietary recommendations advocate sodium restriction which can
be achieved by using sodium depleted salts. Such salts, like as potassium chloride, may contain
unrestricted amounts of chloride. We hypothesized that dietary chloride intake has a separate
effect on blood pressure that is discernable from the effect of sodium. This could implicate that
dietary recommendations should not be limited to sodium alone. In this study, we aim to dis-
cern the effects of sodium and chloride intake on blood pressure and the development of
hypertension in a large prospective cohort study.
Materials and methods
The Prevention of Renal and Vascular End-stage Disease (PREVEND) study is a prospective,
general population-based cohort study investigating the association of albuminuria with renal
and cardiovascular disease. Details of this study are described elsewhere[26]. In total, 8592
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individuals (6000 individuals with a urinary albumin concentration of�10 mg/ L and 2592
individuals with a urinary albumin concentration <10 mg/L) were recruited between 1997
and 1998 and constitute the PREVEND cohort. For the present analyses, we included partici-
pants who took part in the second screening visit, which included an extensive evaluation
including urinary chloride measurements. We excluded participants with a history of cardio-
vascular events (n = 410), with missing urinary chloride values (n = 134), with an estimated
GFR <15 ml/min (n = 2) and those without available follow-up data after the second study
visit (n = 12), leaving 5673 participants for analysis of urinary electrolyte excretion. Urinary
sodium and potassium were available for at least one urinary collection for each participant.
The association with blood pressure at baseline was evaluated in 4655 participants who did not
use antihypertensive drugs. The risk of developing hypertension was evaluated in 3515 patients
without hypertension at baseline. The PREVEND study has been approved by the medical eth-
ics committee of the University Medical Center Groningen. Written informed consent was
obtained from all participants.
Data collection
The procedures at each examination in the PREVEND study have been described previously
[26]. In brief, each examination included 2 visits to an outpatient clinic separated by 3 weeks.
At the first visit, all participants completed a self-administered questionnaire regarding demo-
graphics, cardiovascular and renal disease history, smoking habits, alcohol consumption and
medication use. Medication use, including antihypertensive drugs, was complemented with
information from a pharmacy-dispensing database, which has complete information on the
drug use of approximately 95% of subjects in the PREVEND study. Also, fasting blood sample
was drawn and stored at −80˚C. In the last week before the second visit, subjects had to collect
2 consecutive 24-h specimens after thorough oral and written instruction. During the urine
collection, the participants were asked to avoid heavy exercise as much as possible. Subjects
were also instructed to postpone the urine collection in case of urinary tract infection, men-
struation, or fever. After handing in the urine collections, the urine specimens were stored at
-20˚C. Blood pressure was assessed during both visits in supine position, every minute for 10
and 8 minutes, respectively, with an automatic Dinamap XL Model 9300 series device (John-
son-Johnson Medical, Tampa, FL). The mean of the last 2 recordings from each visit was used.
Laboratory measurements and definitions
Determination of urine electrolyte concentration was performed on the 24-h urine specimens
by indirect potentiometry with a MEGA clinical chemistry analyzer (Merck, Darmstadt, Ger-
many). Serum and urinary creatinine, serum total cholesterol, triglycerides, and glucose were
determined by using Kodak Ektachem dry chemistry (Eastman Kodak, Rochester, NY). Body
mass index was calculated as weight in kilograms divided by height in meters squared. Smok-
ing status was categorized as current or never/former and alcohol intake as rarely (�4 drinks/
month), regularly (>4 drinks/month and< = 3 drinks/day) or often (�4 drinks/day). Educa-
tion was categorized as low (primary education up to those completing intermediate voca-
tional education), average (higher secondary education), and high (higher vocational
education and university). Diabetes mellitus was defined as a fasting plasma glucose�7.0
mmol/L or the use of antidiabetic medication. Hypertension was defined as systolic blood
pressure (SBP) of�140 mmHg, a diastolic blood pressure (DBP) of�90 mmHg, or both or
the use of antihypertensive agents. Estimated glomerular filtration rate (eGFR) was calculated
from the Chronic Kidney Disease Epidemiology Collaboration equation[27].
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Statistical analyses
The urinary chloride, potassium and sodium concentration were multiplied by urine volume
to obtain a value in millimoles per 24-hours (24-h). Correlations between 24-h electrolyte con-
centrations evaluated with Pearson’s correlation coefficient. Second, we evaluated the associa-
tion between 24-h chloride and sodium excretion and blood pressure at baseline using
generalized linear models. Restricted cubic splines were used to examine the optimal func-
tional form of the covariables. Models containing splines were compared with the linear
model using conditional likelihood ratio tests. Model assumptions of homoscedasticity and
normal distribution of errors were verified graphically by residual versus predicted plots and
Q-Q plots. The base models were adjusted for sex and age. Further, fully adjusted models
included urinary creatinine, urinary potassium, body mass index, eGFR, current smoking,
alcohol consumption, family history of premature cardiovascular disease, and educational
attainment. By adjusting for urine creatinine, we adjusted indirectly for both muscle mass and
body dimension. We did not adjust for the presence or absence of albuminuria since we con-
sidered this covariable as potential intermediary factor in the development of hypertension.
Third, the association with development of hypertension was evaluated with multivariable Cox
proportional hazards regression. We evaluated the presence of Interaction between uCl and
age, sex, albuminuria, C-reactive protein, eGFR, smoking, BMI and family history of prema-
ture cardiovascular disease by a likelihood ratio test of the model including a cross-product
term. Further, the proportional hazard assumption was verified by correlating scaled Schoen-
feld residuals and time and no violations were observed. Since previous analyses demonstrated
that the effect of sodium intake on incident hypertension was strongest in patients with albu-
minuria (defined as�15mg/L), we performed a separate analysis in this stratum as sensitivity
analysis[2].
In order to detect potentially influential multicollinearity between sodium and chloride in
the constructed models we calculated the variance inflation factor (VIF). This parameters indi-
cates how much the variance of a given covariable is increased compared to complete absence
of correlation (orthogonality) and is generally agreed to indicate potential model instability if
higher than ten[28]. To quantify the effect of multicollinearity on the parameter estimates, we
performed Ridge regression with increasing biasing parameter (i.e. penalty factor)[29]. Usually
an increasing penalty shrinks coefficients towards zero. Hence, if estimates become larger or
change direction, e.g. from negative to positive, they will be considered to be hampered by col-
linearity[30]. Lastly, we combined urinary sodium and chloride into a single parameter to deal
with the problem of multicollinearity.
Data were missing in 2.3% of participants for HDL-cholesterol and triglycerides and<2%
for all other variables. Missing data were imputed by single imputation methods using predic-




Patient characteristics are displayed in Table 1. In the entire cohort of 5673 patients, mean
baseline 24-h urinary chloride excretion was 135±49 mmol and mean urinary sodium excre-
tion was 145±54 mmol. Of the eligible patients, 4655 patients did not use antihypertensive
drugs. Of 3515 participants with normal blood pressure at baseline, 1023 developed hyperten-
sion during a median follow-up 7.4 (IQR 3.7–7.6) years. The incidence rate of hypertension
was 4.7% per year.
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Correlation between sodium and chloride excretion
In the 5673 participants who attended the second screening visit, there was a very high correla-
tion between 24-h uCl excretion and uNa excretion (Pearson’s r = 0.96, p<0.001), as illustrated
in Fig 1. The mean difference between uNa and uCl was 9.5 mmol [95%CI 21–40]. The corre-
lation between chloride and potassium was much weaker (Pearson’s r = 0.52, p<0.001).
Baseline blood pressure
Urinary chloride excretion was nearly linearly related to systolic and diastolic BP in 4655
patients without antihypertensive medication at baseline (Fig 2). In the linear model, each 10
mmol increase in 24-h uCl excretion was associated with a 0.29 mmHg [95%CI 0.19–0.38]
increase in systolic and 0.17 mmHg [95%CI 0.12–0.22] in diastolic BP. The second model
accounted for potential confounders and attenuated the associations. After adjustment, an
increase of 10 mmol in 24-h uCl was associated with a non-significant 0.09 mmHg [95%CI
-0.02–0.20] higher systolic BP and a significant 0.12 mmHg [95%CI 0.06–0.18] higher diastolic
BP. 24-h UNa excretion had a similar non-significant association with BP (S1 Fig). Analysis of
Table 1. Baseline characteristics.
Variables Entire cohort Without hypertension Without
antihypertensive
drugs
Participants, n 5673 3513 4655
Women, n (%) 2941 (52) 1859 (53) 2409 (51)
Age, years 52 ±12 49 ±10 50 (11)
Race, Caucasian, n (%) 5450 (96) 3373 (96) 4475 (96)
Parental history of CVD, n (%) 2731 (48) 1630 (46) 2191 (47)
Smoking status, current, n (%) 1570 (28) 1022 (29) 1358 (29)
Alcohol consumption, rarely, n (%) 2358 (42) 1371 (39) 1842 (39)
BMI, kg/m2 26.6 ±4.3 25.7 ±3.8 26 (4)
Blood pressure
Systolic, mmHg 126 ±19 118 ±11 123 (17)
Diastolic, mmHg 73 ±9 70 ±7 72 (9)
Antihypertensive drugs, n (%) 1013 (18) 0 (0) 0 (0)
Total cholesterol, mmol/L 5.4 (4.8–6.1) 5.3 (4.7–6.0) 5.4 (4.7–6.1)
HDL cholesterol, mmol/L 1.2 (1.0–1.4) 1.2 (1.1–1.5) 1.2 (1.1–1.5)
Triglycerides, mmol/L 1.1 (0.8–1.6) 1 (0.8–1.5) 1.1 (0.8–1.5)
Lipid-lowering drugs, n (%) 357 (6) 106 (3) 175 (4)
Glucose, mmol/L 4.9 ±0.9 4.8 ±0.7 4.8 ±0.8
Glucose-lowering drugs, n (%) 85 (2) 19 (1) 48 (1)
eGFR, mL/min/1.73m2 81 (71–92) 84 (74–94) 83 (73–93)
Urinary excretion
Chloride, mmol/24h 135 ±50 136 ±48 135 ±49
Sodium, mmol/24h 145 ±54 145 ±53 145 ±54
Potassium, mmol/24h 69 ±22 71 ±22 70 ±22
Creatinine, mmol/24h 12 ±3 13 ±3 13 ±3
Albumin/creatinine, mg/mmol 0.7 (0.5–1.3) 0.6 (0.5–1.0) 0.7 (0.5–1.1)
Values are presented as means with standard deviations or medians with interquartile ranges. CVD, premature
cardiovascular disease; BMI, body-mass index; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration
rate calculated with the Chronic Kidney Disease Epidemiology Collaboration Equation
https://doi.org/10.1371/journal.pone.0228490.t001
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interaction by albuminuria as a continuous variable showed smaller increases in systolic BP
with each increment in uCl at higher values of urinary albumin (p for interaction <0.001).
When specifying tertiles of albuminuria, an increased effect for uCl was observed in the middle
tertile but a decreased effect in the highest tertile. Higher age increased the effect of uCl on sys-
tolic BP whereas it decreased the effect on diastolic BP (p for interaction <0.001).
The model combining both uCl and uNa was hampered by high collinearity (VIF = 12)
resulting in opposite associations for chloride and sodium with systolic and diastolic BP (S2
Fig). When applying Ridge regression, the addition of a small penalty factor resulted in the
coefficients of uCl and uNa to converge. The coefficient of uCl decreased whereas the coeffi-
cient of uNa increased with higher biasing parameter, indicating that the model could not reli-
ably separate the effect of chloride and sodium.
Development of hypertension
In 3513 patients without hypertension at baseline, uCl excretion showed a J-shaped association
with the risk of hypertension (Fig 3). The deviation from linearity was significant (p<0.01);
therefore uCl was modelled as a spline. The spline of uCl was significant in the base model
(p = 0.01) but not in the full model (p = 0.16). The risk of hypertension was lowest at a uCl
level of 151 mmol in the fully adjusted model. The constructed tertiles of uCl excretion showed
a trend towards an increased risk of hypertension in both the lowest and highest tertile
(Table 2). No significant interactions were observed. The association of uNa with the risk of
hypertension was non-significant and similar to uCl (S3 Fig). Sensitivity analyses performed in
patients with a albuminuria showed a stronger association for both chloride and sodium with
risk of hypertension (p = 0.07 for chloride and p = 0.02 for sodium after full adjustment,
Table 2).
Combining uCl and uNa in the same model resulted in an inverse association of uCl with
the risk of hypertension (Fig 4), probably because of overlapping information (VIF = 11). In





























Fig 1. Correlation between urinary sodium and chloride excretion.
https://doi.org/10.1371/journal.pone.0228490.g001
Chloride excretion and risk of hypertension
PLOS ONE | https://doi.org/10.1371/journal.pone.0228490 February 5, 2020 6 / 14
the Ridge regression model the initially negative coefficient of uCl became positive while the coef-
ficient for uNa remained positive with increasing penalty factor, demonstrating the impact of
multicollinearity. Next, we combined uCl and uNa into a single index (Fig 5). The difference
between uNa and uCl showed a linear relation with the risk of hypertension. Each 10 mmol incre-
ment between uNa and uCl excretion (indicating a higher sodium than chloride intake) resulted
in additional risk of 5% (HR 1.05, 95%CI 1.01–1.09), which disappeared after adjustment
(HR1.02, 95%CI 0.98–1.06). Additional analysis with the uNa to uCl ratio showed a similar pat-
tern with a non-significant increased risk of incident hypertension for higher ratios indicating
more sodium compared to chloride intake (S4 Fig). For both combined indices, further adjust-
ment for the urinary sodium to potassium ratio did not change the slope of associations.
Discussion
The cation sodium is often used interchangeably for salt (i.e. sodium chloride) and is the
alleged culprit of the adverse effects on blood pressure and cardiovascular disease. The most













50 100 150 200 250













50 100 150 200 250











50 100 150 200 250











50 100 150 200 250
Fig 2. 24-h urinary chloride excretion in relation to blood pressure at baseline, with density plot. Adjusted for age and
sex (left) and after additional adjustment (right) for age, sex, urinary creatinine, urinary potassium, smoking, body-mass
index, history of diabetes, family history of premature cardiovascular disease, educational attainment, alcohol and
estimated glomerular filtration rate. SBP, systolic blood pressure; DBP, diastolic blood pressure.
https://doi.org/10.1371/journal.pone.0228490.g002
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abundant accompanying anion, chloride, has received little attention but could have a pivotal
role. In this study we showed the difficulty of disentangling the effects of sodium and chloride
because sodium and chloride urinary excretions were highly correlated. Nonetheless, differ-
ences in sodium versus chloride excretions occurred at an individual level. Higher 24-h uCl
excretion was positively but not significantly associated with baseline BP and development of
hypertension similar to and inseparable from the effect of higher uNa excretion. Therefore, we
argue that the role of chloride cannot be discarded and should be considered in clinical studies
and dietary recommendations on salt intake.
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Fig 3. Urinary chloride excretion and the risk of hypertension. Adjusted for age and sex (left) and fully adjusted model (right) for urinary
creatinine, urinary potassium, smoking, body-mass index, history of diabetes, family history of premature cardiovascular disease, educational
attainment, alcohol and estimated glomerular filtration rate. HR, hazard ratio.
https://doi.org/10.1371/journal.pone.0228490.g003
Table 2. Association between chloride excretion per 24-h in tertiles and risk of hypertension. Separately shown in
overall population (n = 3513) and patients with albuminuria (>15mg/24h, n = 638).
1st tertile 2nd tertile 3rd tertile
<111 mmol/24h 111–151 mmol/24h >151 mmol/24h
Overall population
No. of cases 344 311 368
Age and sex-adjusted HR 1.16 (0.99–1.35) 1.0 (reference) 1.20 (1.03–1.40)
Multivariable adjusted HRa 1.19 (1.02–1.40) 1.0 (reference) 1.06 (0.91–1.25)
Patients with albuminuria
No. of cases 75 82 137
Age and sex-adjusted HR 1.30 (0.95–1.79) 1.0 (reference) 1.29 (0.98–1.70)
Multivariable adjusted HRa 1.39 (0.99–1.95) 1.0 (reference) 1.22 (0.91–1.63)
Hazard ratio’s derived from Cox proportional-hazards model with chloride as independent variable in three
categories based on tertiles of 24-h chloride excretion. The 2nd tertile serves as reference category.
a Additionally adjusted for smoking, BMI, diabetes, TC/HDL ratio, urinary potassium, urinary creatinine, log-
transformed eGFR, alcohol consumption, family history of premature CVD and educational attainment.
https://doi.org/10.1371/journal.pone.0228490.t002
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In this observational cohort study, we tried to separate the collinear effects of both ions
with different analytical methods. The negative effects of multicollinearity in statistical models
primarily pertain to inadequate estimates of uncertainty such as confidence intervals and p-
values[28]. Further, disentangling the independent contribution of the correlated covariables
poses a problem when they contain overlapping information, like sodium and chloride.
Including both variables in one statistical model can yield effect estimates of implausible mag-
nitude or estimates in opposed direction of what was expected[30]. Potential solutions are
removing either variable from the model, using Ridge regression, combining the two covari-
ables into a single index or using principal component analysis[28,29]. In the present studies
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Fig 4. Urinary chloride (left) and sodium (right) excretion and the risk of hypertension incorporated in the same model. Age
and sex adjusted. HR, hazard ratio.
https://doi.org/10.1371/journal.pone.0228490.g004
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Fig 5. Difference in urinary sodium and chloride excretion and the risk of hypertension (left) and after further adjustment (right).
Adjusted for urinary creatinine, urinary potassium, smoking, body-mass index, history of diabetes, family history of premature
cardiovascular disease, educational attainment, alcohol and estimated glomerular filtration rate (right). HR, hazard ratio.
https://doi.org/10.1371/journal.pone.0228490.g005
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we applied the first three approaches. First, we evaluated chloride and sodium excretion sepa-
rately and showed similar associations with BP and risk of hypertension for each ion. Next, we
applied Ridge regression, which increases the variance relative to the covariance in order to
limit the effect of multicollinearity[29]. However, the estimate produced by the Ridge model
are biased and can only be used to get an impression of how much the model is affected by
multicollinearity. In this study, the introduction of a small penalty factor in the cross-sectional
analyses yielded models with coefficients for sodium and chloride which converged to each
other. This convergence indicates that both variables contain similar information. In the pro-
spective analysis, the coefficient for chloride changed sign (i.e. became positive) after applying
a penalty factor, again illustrating the effect of multicollinearity. Lastly, we combined sodium
and chloride into a single variable both as their difference and ratio. Both indices showed that
a higher sodium compared to chloride intake might have an adverse effect on the risk of hyper-
tension, although the association was non-significant. The lower sodium to chloride ratio
could also indicate a higher intake of other cations, notably potassium, which has a blood pres-
sure lowering effect[32]. Nonetheless, the adjusted models incorporated potassium or the
sodium to potassium ratio and showed a weaker, but still positive association. Further, in the
cross-sectional analysis a steeper association of 24-h chloride excretion with BP was observed
at higher levels of chloride intake very similar to the stronger effects reported at higher intake
of sodium in other studies[33]. In the prospective analysis, we observed a J-shaped association
for the risk of developing hypertension. Such an association is also observed in studies evalua-
tion sodium excretion and risk of cardiovascular events or death[34,35]. A possible explana-
tion is reverse causation, i.e. people reduce sodium and chloride intake due to illness or health
advice. We excluded participants with previous cardiovascular disease and studied a general
population sample, which is considered to result in a lower risk of reverse causation[36].None-
theless, the fact that the risk associated with low 24-h uCl was higher in patients with albumin-
uria who are more likely to have had dietary counseling, might indicate some remaining
reverse causation.
The focus of current dietary recommendations on sodium follows from the selective evalua-
tion of cations in dietary studies thus far. The present study is the first to attempt to separate
the effects of the cation and anion and showed their high correlation and comparable effects
on blood pressure. The current recommendations on selective sodium restriction are based on
the large observational studies such as INTERSALT, INTERMAP and PURE[33,37–39]. Fur-
ther, meta-analyses of more than 30 trials confirmed that reducing sodium intake lowers BP
[23,40]. Although these studies measured a range of cations, creatinine and albumin, they did
not evaluate anions. The interventions to reduce sodium intake consisted mainly of dietary
advice or provision of key foods with lower sodium content, both of which are likely to have
reduced chloride intake as well. However, sodium and chloride are not completely tied
together. Although sodium is mostly consumed as sodium chloride in a typical Western diet,
they do not necessarily go hand in hand[24]. In more than thousand food items, the sodium
chloride content was calculated by measuring the sodium and chloride ion separately and con-
verting the measured ion concentrations into the corresponding salt. The estimated salt con-
tent was different for seven out of ten foods. The differences ranged up to a 43% higher salt
content for specific food items for the sodium-based approach. This implies that sodium and
chloride may originate from different natural sources or food additives. Further, food compo-
sition and main sources of sodium and chloride differ by cultural context and dietary habits
around the world[41]. In addition, specific dietary recommendations like the use of sodium-
depleted salts (e.g. potassium chloride) could result in isolated higher chloride intake. In stud-
ies evaluating potassium chloride supplementation, the beneficial effect on BP could be due to
the introduction of potassium irrespective of the potential adverse effect of sodium or chloride
Chloride excretion and risk of hypertension
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[42]. In conclusion, our results agree with previous observational studies on the effect of
sodium intake on BP by demonstrating a similar positive association. However, thus far
sodium was used as proxy for salt and the effect of chloride was not evaluated. Although
sodium restricting is likely to lower chloride intake, food composition and salt replacements
can indeed vary with respect to ion content. Therefore, the findings from this study encourage
reevaluation of the dietary salt recommendations based on sodium only.
To our knowledge this is the first study to quantify the correlation between sodium and
chloride excretion and their association with BP and risk of hypertension in a large prospective
Western cohort. Strengths of the current study include the large number of participants, the
long follow-up time and the availability of two 24-h urine collections per individual to reliably
predict electrolyte intake[43]. In addition, we used different statistical approaches to evaluate
the impact of multicollinearity and demonstrated the inability to clearly separate the effects of
chloride and sodium. The combination of both ions into a single index offered additional
insight, but only shed light on the ratio of the two ions instead of their individual contribution.
The observational nature of this study was the major limitation and prevented us from separat-
ing the effects of sodium and chloride. Further, in the present analyses the associations
between uCl and uNa and incident hypertension were of similar direction but no longer signif-
icant after full adjustment, in contrast to previous findings. This can be explained by the two
thousand fewer available participants without hypertension at the second screening visit when
uCl was measured, as well as by previous reports showing the most pronounced associations
in patients with hypertension or markers of endothelial dysfunction[2,33]. We explored
whether the effect of chloride was modified by vascular endothelial dysfunction defined by
albuminuria and observed a stronger effect of uCl on development of hypertension with higher
urinary albumin excretion in concurrence with previous work[2]. Lastly, higher age attenuated
the effect of uCl on baseline systolic BP while at the same increasing the effect on diastolic BP,
which might indicate differential effect of salt loading on BP in older people[39].
In conclusion, the adverse effects of chloride and sodium measured by 24-h urinary excre-
tion were difficult to disentangle due to their high correlation and comparable non-significant
effects on blood pressure and risk of hypertension. Hence, the alleged adverse effects of a high
salt intake could be due to sodium, chloride or both. An intervention study with different com-
binations of cations and anions would be required in order to understand their relative contri-
bution to the development of hypertension. For now, guidelines committees should consider
formulating sodium chloride targets rather than sodium targets alone.
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